Boothbay Fund Management’s Shuttle Pharmaceuticals SHPH Stock Holding History

Boothbay Fund Management’s Portfolio SHPH Stock Details SHPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,036	Closed	-$13.8K	–	2593
2026 Q1	$13.8K	Hold	2,036	–	–	﹤0.01%	1986
2025 Q4	$36.6K	Buy	+2,036	New	+$52.1K	﹤0.01%	1844

Other funds holding SHPH

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

KFA

Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

Boothbay Fund Management's SHPH Position: Q2 2026 in Review

Boothbay Fund Management sold out of Shuttle Pharmaceuticals (SHPH) in Q2 2026, closing a stake of 2,036 shares — an estimated $13.8K sold.

Boothbay Fund Management first reported a position in SHPH in Q4 2025 and held it in 2 quarters. The position peaked at $36.6K in Q4 2025. 5 funds tracked by Wall St. Rank hold SHPH as of Q2 2026.

Boothbay Fund Management reported no remaining Shuttle Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Boothbay Fund Management sold 2,036 Shuttle Pharmaceuticals shares in Q2 2026, an estimated $13.8K.
Boothbay Fund Management first reported a position in Shuttle Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Boothbay Fund Management's Shuttle Pharmaceuticals position peaked at $36.6K in Q4 2025.
5 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.